WASHINGTON, D.C. — Wilson Sonsini Goodrich & Rosati has announced the addition of Jodi Daniel as a partner in its Regulatory Department, further strengthening the firm’s growing capabilities in health privacy, digital health, and healthcare innovation. Based in the firm’s Washington, D.C., office, Daniel brings decades of leadership in both government and private-sector healthcare regulation, positioning her as one of the most experienced digital health attorneys in the country.
A former senior policymaker at the U.S. Department of Health and Human Services (HHS), Daniel played a central role in shaping foundational health information technology policy, including HIPAA and interoperability regulations. She served as the founding director of the Office of the National Coordinator for Health Information Technology (ONC), where she led the development of federal health IT strategy to enhance care quality, reduce costs, and expand patient access to electronic health tools.
Daniel joins Wilson Sonsini from Crowell & Moring, where she was a partner in the Health Care Group, led the firm’s Digital Health Practice, and helped launch two strategic consulting affiliates. Her background also includes roles at the FDA, CMS, FTC, and ONC, where she navigated issues related to telehealth, health data exchange, regulatory compliance, and FDA oversight of digital technologies.
“Digital health continues to be one of the most dynamic and rapidly growing sectors we serve,” said Doug Clark, managing partner at Wilson Sonsini. “Jodi has spent more than 20 years shaping the regulations that made this sector what it is today. Her insights and leadership will significantly enhance our ability to support clients across health technology, life sciences, and regulatory compliance.”
Brent Snyder, who leads the firm’s Regulatory and Compliance Department, emphasized that Daniel’s addition expands Wilson Sonsini’s strength in advising on HIPAA compliance, privacy and security, FDA regulation, and the ethical implications of AI and emerging health technologies. “Her experience will be instrumental as we continue to support innovators at the intersection of healthcare and technology,” Snyder said.
Daniel expressed enthusiasm about joining Wilson Sonsini, citing the firm’s reputation in regulatory, privacy, and AI matters. “What drew me to Wilson Sonsini was the firm’s leadership across transactional, privacy, data, AI, and FDA regulatory matters,” she said. “Its depth in these areas—along with a longstanding commitment to innovation—offers an ideal platform to expand my practice and provide strategic counsel to clients advancing healthcare and improving the patient experience.”
Daniel remains active in national health policy discussions and currently serves on the steering committee of the National Academy of Medicine’s initiative to develop a Health Care Artificial Intelligence Code of Conduct.
She holds a B.A. in economics and community health from Tufts University, an M.P.H. from Johns Hopkins University, and a J.D. from Georgetown University Law Center, where she graduated magna cum laude and was inducted into the Order of the Coif.
